Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2021

Sep 3, 2021

30786_dirs_2021-09-03_c7be566f-0e06-4e37-92c1-75acd47c6e08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-01

Reporting Person: RAMALINGAM AJIT (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-02 Bio-Rad A Common Stock M 240 Acquired 473.3993 Direct
2021-09-02 Bio-Rad A Common Stock F 83 $825.77 Disposed 390.3993 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-01 Restricted Stock Units $0 A 676 Acquired Bio-Rad A Common Stock (676) Direct
2021-09-02 Restricted Stock Units $0 M 240 Disposed Bio-Rad A Common Stock (240) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 11.7355 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2021.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F5: On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.